Eisai, Purdue Join Up To Take Insomnia Drug Into Phase III
Eisai is teaming up with Purdue for the global development and commercialization of a dual orexin receptor, lemborexant, for insomnia and possibly other potential indications.
Eisai is teaming up with Purdue for the global development and commercialization of a dual orexin receptor, lemborexant, for insomnia and possibly other potential indications.